Viewing Study NCT07292168

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-24 @ 5:37 PM
Ignite Modification Date: 2026-02-25 @ 6:25 PM
Study NCT ID: NCT07292168
Status: ACTIVE_NOT_RECRUITING
Last Update Posted: 2025-12-18
First Post: 2025-11-20
Is NOT Gene Therapy: True
Has Adverse Events: False
Brief Title: A Phase 1b/2 Study of the Safety and Efficacy of the Monoclonal Antibody OM-RCA-01 in Patients With Metastatic Tumors Expressing Fibroblast Growth Factor Receptor 1
Sponsor: Kidney Cancer Research Bureau
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Renal Cell Carcinoma Metastatic View
None Prostate Cancer Metastatic View
None Non-small Cell Lung Cancer Metastatic View
None Breast Cancer Metastatic View
None Head & Neck Cancer View
Keywords:

Keywords

Keyword Brief Keyword Text View
None metastatic cancer View
None resistance View
None monoclonal antibody View
None fibroblast growth factor receptor 1 View
None OM-RCA-01 View
None kidney cancer View
None prostate cancer View
None head & neck cancer View
None lung cancer View
None breast cancer View